Increased reporting of fatal pneumonitis associated with immune checkpoint inhibitors: a WHO pharmacovigilance database analysis
Melissa Moey, Paul Gougis, Vincent Goldschmidt, Douglas B. Johnson, Bénédicte Lebrun‐Vignes, Javid J. Moslehi, Jacquès Cadranel, Joe‐Elie Salem
Abstract
<b>There was an increased reporting of immune checkpoint inhibitor (ICI)-pneumonitis over the past few years with earlier time to onset of fatal ICI-pneumonitis, which was associated with more respiratory failure and tumour progression</b>http://bit.ly/32GW51a
Topics & Concepts
MedicinePneumonitisPharmacovigilanceHypersensitivity pneumonitisRespiratory failureDatabaseAdverse effectInternal medicineLungComputer scienceCancer Immunotherapy and BiomarkersTuberculosis Research and EpidemiologyDrug-Induced Adverse Reactions